-+ 0.00%
-+ 0.00%
-+ 0.00%

Argus Research Reiterates Buy on Zimmer Biomet Holdings, Maintains $125 Price Target

Benzinga·10/22/2026 14:56:09
Listen to the news
Argus Research analyst David Toung reiterates Zimmer Biomet Holdings (NYSE:ZBH) with a Buy and maintains $125 price target.